DONOVAN JOANNE M. (CMO) sold 63.0% of their position (16.36K shares) of EDGEWISE THERAPEUTICS, INC. on the open market
Open‑market sale worth $506.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/30/2026ACC: 0001644087-26-000001
Officer· CMO
Since Apr 2021
-16.36K
Net shares
Net seller
$506.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.62K
Price / share
$30.98
Trade value
$298.10K
% of position
37.1%
3/27/2026
25.95K→16.33K
Common Stock
Direct
Shares
−6.74K
Price / share
$30.98
Trade value
$208.64K
% of position
41.2%
3/27/2026
16.33K→9.60K
Total
Net shares
−16.36K
Net value
-$506.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | S · Sale | −9.62K | $30.98 | $298.10K | 37.1% | 25.95K | 16.33K |
| Common Stock Direct | 3/27/2026 | S · Sale | −6.74K | $30.98 | $208.64K | 41.2% | 16.33K | 9.60K |
| Total | −16.36K | -$506.73K | ||||||
Derivative Transactions0
No derivative transactions reported